- Home
- RLAY vs MHH Comparison
RLAY vs MHH Comparison
Compare RLAY & MHH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RLAY | MHH |
|---|---|---|
| Founded | 2015 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 82.5M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | RLAY | MHH |
|---|---|---|
| Price | $7.41 | $7.20 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $16.00 | N/A |
| AVG Volume (30 Days) | ★ 2.1M | 24.6K |
| Earning Date | 02-25-2026 | 02-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $8,355,000.00 | ★ $196,657,000.00 |
| Revenue This Year | $19.96 | N/A |
| Revenue Next Year | N/A | $4.50 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 1.24 |
| 52 Week Low | $1.78 | $6.20 |
| 52 Week High | $9.04 | $15.14 |
Technical Indicators
Market Signals| Indicator | RLAY | MHH |
|---|---|---|
| Relative Strength Index (RSI) | 40.00 | 50.07 |
| Support Level | $7.62 | $6.80 |
| Resistance Level | $8.38 | $7.53 |
| Average True Range (ATR) | 0.42 | 0.41 |
| MACD | -0.12 | 0.01 |
| Stochastic Oscillator | 3.42 | 61.29 |
Price Performance
Historical ComparisonAbout RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).
About MHH Mastech Digital Inc
Mastech Digital Inc is a provider of Digital Transformation IT Services. The Company offers data & analytics solutions & IT staffing services for both digital & mainstream technologies. The Group has two segments. Its Data & Analytics Services segment delivers specialized data management, data engineering, customer experience consulting, data analytics & cloud services to customers globally. IT Staffing Services segment combines technical expertise with business process experience to deliver a broad range of services in digital & mainstream technologies. The company derives a majority of its revenue from IT staffing services. Geographically, the majority of revenue is generated from the United States.